Amwill Health Care , a prominent player in the healthcare sector, has released its unaudited financial results for the half year ended September 30, 2025. The company reported a significant decline in profit and a decrease in revenue, while also providing an update on the utilization of its Initial Public Offering (IPO) proceeds.

Financial Performance

The company's financial performance for H1 FY2026 shows a notable decline compared to the same period in the previous year:

Amwill Health Care experienced a substantial 40.55% decrease in profit, dropping from ₹651.66 lakhs to ₹387.40 lakhs. This decline was accompanied by an 8.43% reduction in revenue from operations, which fell to ₹2,120.50 lakhs from ₹2,315.60 lakhs in the previous corresponding period.

Total expenses rose by 19.59% to ₹1,733.90 lakhs, with a significant increase in employee benefit expenses, which grew by 21.61% to ₹424.37 lakhs. As a result of these factors, earnings per share decreased from ₹4.18 to ₹1.94, representing a 53.59% decline.

IPO Proceeds Utilization

Amwill Health Care provided an update on the utilization of its IPO proceeds:

The company has utilized ₹3,288.08 lakhs of its total IPO proceeds of ₹4,888.00 lakhs, representing 67.27% of the funds raised. The remaining ₹1,599.92 lakhs are currently unutilized and have been invested in term deposits (₹1,546.61 lakhs) and kept in current accounts (₹53.30 lakhs).

Management Statement

In its statement to the Bombay Stock Exchange, the company confirmed that there has been no deviation or variation in the utilization of IPO proceeds from the objects stated in the Prospectus dated February 10, 2025. The Audit Committee has reviewed and approved this statement.

Amwill Health Care remains committed to its growth strategy and efficient use of resources. However, the significant decline in profit and increase in expenses may require careful monitoring in the coming quarters.

Amwill Health Care has disclosed its Initial Public Offering (IPO) fund utilization report for the half-year ended September 30, 2025, demonstrating strict adherence to its stated objectives. The company, which raised funds through equity shares, has provided a detailed breakdown of its expenditure in line with the original allocations.

IPO Fund Allocation and Utilization

The company's fund utilization as of September 30, 2025, is summarized in the following table:

Unutilized Funds

The company reported that the unutilized IPO proceeds, amounting to ₹1,546.61 lakhs, have been invested in term deposits with a bank. An additional ₹53.30 lakhs are maintained in a current account for intended purposes.

Audit Committee Review

The Audit Committee of Amwill Healthcare Limited reviewed the fund utilization statement at its meeting held on November 04, 2025. The committee confirmed that there has been no deviation or variation in the utilization of IPO proceeds from the objectives stated in the company's prospectus dated February 10, 2025.

Management Statement

Anshu Anshuman, Company Secretary and Compliance Officer of Amwill Healthcare Limited, stated, "We hereby confirm that during the half-year ended September 30, 2025, of the financial year 2025-26, there is no deviation or variation in the utilization of proceeds of the IPO from the objects stated in the Prospectus."

Transparency and Compliance

The company's disclosure aligns with Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019. This level of transparency provides investors with a clear view of how the IPO funds are being utilized and ensures compliance with regulatory requirements.

Amwill Healthcare's meticulous reporting and adherence to its stated objectives demonstrate a commitment to transparency and responsible fund management, which may bolster investor confidence in the company's financial practices.